biote BTMD
- Market cap
- $38.4M
- PE
- 10.7×
- 5y median 12.3×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 0.2×
- EV/EBIT
- 10.5×
- Revenue, 12 months
- $183.5M
- −8% on a year ago
- Net margin
- 3.2%
- Free cash flow yield
- n/m
- a yield above 40% (usually a one-off)
biote trades at 10.7× trailing earnings, near its ten-year median. Revenue was $183.5M over the last twelve months, down 8% on a year earlier with a 3% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $45.6M+9% | $45.7M+3% | $46.8M+4% | $49.2M−0% | $51.4M+13% | $49.8M+9% | $49M+5% | $48.9M−1% | $48M−7% | $46.4M−7% | $44.9M−8% | $44.2M−10% | |
| Cost of revenue | $14.2M+6% | $14M−9% | $13.5M−3% | $15.4M−3% | $15.3M+8% | $14M+0% | $12.6M−6% | $13.9M−10% | $13.5M−11% | $14.8M+6% | $14M+11% | $15.3M+10% |
| Gross profit | $31.4M+10% | $31.7M+9% | $33.4M+8% | $33.8M+1% | $36.1M+15% | $35.8M+13% | $36.4M+9% | $35M+4% | $34.4M−5% | $31.6M−12% | $31M−15% | $28.9M−17% |
| SG&A | $23.8M+14% | $26.2M+20% | $22.9M−1% | $27.6M+7% | $23.9M+1% | $33M+26% | $26.7M+16% | $24.2M−12% | $26.2M+9% | $24.7M−25% | $27.8M+4% | $32.4M+34% |
| $7.6M−3% | $5.5M−25% | $10.4M+32% | $6.2M−19% | $12.2M+60% | $2.8M−50% | $9.7M−7% | $10.8M+73% | $8.3M−32% | $6.8M+147% | $3.2M−67% | −$3.5M | |
| Interest expense | $1.5M+9% | $1.5M−2% | $1.7M+1% | $2.6M+57% | $3.5M+132% | $3.2M+109% | $2.9M+75% | $2.9M+11% | $2.7M−23% | $2.5M−23% | $2M−32% | $2.2M−24% |
| Pre-tax income | $23.5M+3130% | $9.3M−30% | −$3.3M−84% | −$10.3M−15% | $15.9M−33% | −$1.2M | $17.5M | $6.1M | $8.5M−47% | $5.6M | $3.3M−81% | −$7.1M |
| $3.9M+1556% | −$2.7M | $2.4M+281% | $73K−92% | $3.2M−17% | −$4.7M+71% | $1.6M−33% | $2.1M+2845% | −$765K | $3M | $662K−59% | $296K−86% | |
| Net income | $7.5M+50100% | $7.7M+377% | −$4.2M−39% | −$7.1M+38% | $10.7M+42% | $3.7M−52% | $13.7M | $3.2M | $8.2M−24% | $2M−47% | $2.3M−83% | −$6.6M |
| $0.24 | $0.23+35% | −$0.12−69% | −$0.21−16% | $0.33+38% | $0.10−57% | $0.37 | $0.10 | $0.22−33% | $0.05−50% | $0.06−84% | −$0.23 | |
| 31M+308% | 34M+260% | 34.6M+97% | 33.1M+60% | 32.3M+4% | 37.4M+10% | 37M+7% | 31.7M−4% | 36.7M+14% | 36M−4% | 36M−3% | 28.6M−10% |
Gross profit: 21 periods, Q2 FY21 to Q2 FY26: not printed by the filing, worked out from its own lines.
EPS, diluted: 5 periods, Q4 FY21 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: Q4 FY21: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. 4 periods, Q4 FY22 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Basic Materials nearest biote's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| BTMDbiote | $38.4M | 10.7× | 12.3× | 0.2× | −8% | 3.2% | |
| BWENBroadwind | $68.6M | n/m | 12.9× | 0.5× | +17% | 3.9% | |
| FTLFFitlife Brands | $78.4M | 13.5× | 15.3× | 0.8× | +61% | 6.2% | |
| SMIDSmith Midland | $112.9M | 14.7× | 18.2× | 1.3× | −2% | 8.6% | |
| NAGENiagen Bioscience | $192.3M | 13.5× | 27.0× | 1.5× | +11% | 12.4% | |
| SNDSmart Sand | $201.8M | 18.3× | 12.5× | 0.5× | +27% | 2.7% | |
| ALTOAlto Ingredients | $280M | 5.4× | 13.8× | 0.3× | +1% | 5.5% | |
| FRDFriedman Industries | $301.7M | 10.9× | 9.3× | 0.4× | +62% | 3.6% | |
| IDRIdaho Strategic Resources | $303.5M | 13.5× | 25.5× | 6.0× | +67% | 44.0% | |
| VFFVillage Farms International | $314.9M | 14.3× | 18.3× | 1.4× | −3% | 9.8% | |
| Peer median | $201.8M | 13.5× | 15.3× | 0.8× | +17% | 6.2% |
More on biote
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #1of 17Chemicals stocks with the lowest PE ratio
- #10of 81Materials stocks with the lowest PE ratio
- #6of 43Chemicals stocks with the lowest price to sales ratio
- #5of 23Chemicals stocks with the lowest EV/EBIT
Its groups
About
- Industry
- Chemicals
- Sector
- Basic Materials
Valuation data, not investment advice. Prices as of .